Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Osada

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive BehaviorTakuya Osada, Kensuke Kaneko, William R Gwin, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 8, 2023
The use of histotripsy as intratumoral immunotherapy beyond tissue ablation-the rationale for exploring the immune effects of histotripsyTakuya Osada, Xiaoning Jiang, Yuhang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancerMichael A Morse, Angeles A Secord, Kimberly Blackwell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2015
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumorsTakuya Osada, Koji Nagaoka, Masashi Takahara, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2008
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patientsTakuya Osada, Gabriel Chong, Robert Tansik, et al.
Cancer Research|May 3, 2011
Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutationsTakuya Osada, Minyong Chen, Xiao Yi Yang, et al.
Dynamic Medicine : DM|January 16, 2008
Low-volume muscular endurance and strength training during 3-week forearm immobilization was effective in preventing functional deteriorationMika Matsumura, Chihoko Ueda, Kiyoshi Shiroishi, et al.
Advances in Experimental Medicine and Biology|June 4, 2004
The effects of food intake on muscle oxygen consumption: noninvasive measurement using NIRSChihoko Ueda, Takafumi Hamaoka, Norio Murase, et al.
Journal for Immunotherapy of Cancer|September 28, 2022
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancersKensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive BehaviorTakuya Osada, Kensuke Kaneko, William R Gwin, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 8, 2023
The use of histotripsy as intratumoral immunotherapy beyond tissue ablation-the rationale for exploring the immune effects of histotripsyTakuya Osada, Xiaoning Jiang, Yuhang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancerMichael A Morse, Angeles A Secord, Kimberly Blackwell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2015
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumorsTakuya Osada, Koji Nagaoka, Masashi Takahara, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2008
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patientsTakuya Osada, Gabriel Chong, Robert Tansik, et al.
Cancer Research|May 3, 2011
Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutationsTakuya Osada, Minyong Chen, Xiao Yi Yang, et al.
Dynamic Medicine : DM|January 16, 2008
Low-volume muscular endurance and strength training during 3-week forearm immobilization was effective in preventing functional deteriorationMika Matsumura, Chihoko Ueda, Kiyoshi Shiroishi, et al.
Advances in Experimental Medicine and Biology|June 4, 2004
The effects of food intake on muscle oxygen consumption: noninvasive measurement using NIRSChihoko Ueda, Takafumi Hamaoka, Norio Murase, et al.
Journal for Immunotherapy of Cancer|September 28, 2022
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancersKensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, et al.
Pageof 14